JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. (Q55548365)
Jump to navigation
Jump to search
scientific article published on 11 June 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. |
scientific article published on 11 June 2018 |
Statements
1 reference
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. (English)
1 reference
Gina A Montealegre Sanchez
Adam Reinhardt
Suzanne Ramsey
Helmut Wittkowski
Philip J Hashkes
Susanne Schalm
Sara Murias
Jason A Dare
Diane Brown
Deborah L Stone
Ling Gao
Thomas Klausmeier
Dirk Foell
Adriana A de Jesus
Dawn C Chapelle
Samantha Dill
Robert A Colbert
Bahar Kost
Michelle O'Brien
James C Reynolds
Les R Folio
Katherine R Calvo
Scott M Paul
Nargues Weir
Alessandra Brofferio
Ariane Soldatos
Angelique Biancotto
Edward W Cowen
John J Digiovanna
Massimo Gadina
Andrew J Lipton
Colleen Hadigan
Steven M Holland
Joseph Fontana
Ahmad S Alawad
Rebecca J Brown
Kristina I Rother
Theo Heller
Kristina M Brooks
Parag Kumar
Stephen R Brooks
Meryl Waldman
Harsharan K Singh
Volker Nickeleit
Maria Silk
Apurva Prakash
Jonathan M Janes
Seza Ozen
Paul G Wakim
Paul A Brogan
William L Macias
Raphaela Goldbach-Mansky
11 June 2018
1 reference